Swedish Orphan Biovitrum AB (Publ) SWEDISH ORPHAN BIOVITRUM ORD SHS
Swedish Orphan Biovitrum AB (Publ.../ SE0000872095 /
0MTD
24/05/2024 17:23:00
|
Chg.
-
|
Volume |
Bid17:25:05 |
Ask17:25:05 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
279.00SEK
|
-
|
92,977 Turnover: 389,718.80 |
-Bid Size: - |
-Ask Size: - |
115.8 bill.SEK |
- |
43.75 |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
7.47 SEK |
-16.26% |
EPS Diluted: |
- SEK |
-16.40% |
Revenues per Share: |
62.43 SEK |
2.93% |
Book Value per Share: |
95.57 SEK |
11.63% |
Cash Flow per Share: |
12.61 SEK |
-16.23% |
Dividend per Share: |
- SEK |
- |
Total |
in mill. |
|
Revenues: |
22,123.00 SEK |
17.74% |
Net Income: |
2,409.00 SEK |
-8.68% |
Operating Cash Flow: |
4,470.00 SEK |
- |
Cash and Cash Equivalents: |
904.00 SEK |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
43.75 |
35.74 |
P/S Ratio: |
5.23 |
4.28 |
P/BV ratio: |
3.42 |
2.79 |
P/CF Ratio: |
25.91 |
21.17 |
PEG: |
-2.69 |
-2.20 |
Earnings Yield: |
2.29% |
2.80% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
115.8 bill. SEK |
94.61 bill. SEK |
Free Float Market Cap.: |
- SEK |
- SEK |
Market Cap. / Employee: |
65.35 mill. SEK |
53.39 mill. SEK |
Shares Outstanding: |
354.36 mill. |
|
Profitability
Gross Profit Margin: |
77.42% |
EBIT Margin: |
18.38% |
Net Profit Margin: |
10.89% |
Return on Equity: |
7.11% |
Return on Assets: |
3.25% |
Financial Strength
Liquidity I / Cash Ratio: |
4.73% |
Liquidity II / Quick Ratio: |
31.80% |
Liquidity III / Current Ratio: |
66.36% |
Debt / Equity Ratio: |
118.58% |
Dynam. Debt / Equity Ratio: |
898.43% |
Efficiency
Employees: |
1,772 |
Personal Expenses / Employee: |
- SEK |
Revenues / Employee: |
12,484,762.98 SEK |
Net Income / Employee: |
1,359,480.81 SEK |
Total Assets / Employee: |
41,775,959.37 SEK |
* Fiscal Year End: |
31/12/2023 |
Accounting Standard: |
IFRS |